title: Treatment decisions and contemporary versus pending treatments for hepatitis C.
abstract: The primary aim of antiviral therapy for chronic hepatitis C (CHC) is the prevention of progressive disease. A response to interferon (IFN) treatment is associated with an improvement in all-cause mortality and liver-related mortality from hepatitis C. Unless contraindicated, patients with CHC are thus potential candidates for treatment. Improved response rates are observed in patients with HCV genotype 1 infection treated with first-generation protease inhibitors. However, treatment with current first-generation protease inhibitors and IFN is complex and can result in appreciable adverse effects. The advent of potent, pan-genotypic all-oral direct-acting antiviral (DAA) regimens necessitates a critical examination of the immediate application of PEG-IFN, ribavirin and DAA regimens in patients with CHC. Current guidelines and position statements do not make clear recommendations, and are behind the emerging data. Some aspects of the conundrums facing physicians and patients are summarized in this Review. Cirrhosis presents an immediate threat of disease, and ideally treatment should be targeted at those patients who have advancing or advanced disease; unfortunately, a disparity exists, as response rates are reduced in patients with cirrhosis and the risks of adverse events are increased. On balance, patients with mild disease could consider deferring treatment.
authors.affiliation: UCL Institute for Liver and Digestive Health, Royal Free London NHS Foundation Trust, Rowland Hill Street, London NW3 2PF, UK.
authors.forename: Paul M
authors.initials: PM
authors.lastname: Trembling
authors.forename: Sudeep
authors.initials: S
authors.lastname: Tanwar
authors.forename: William M
authors.initials: WM
authors.lastname: Rosenberg
authors.forename: Geoffrey M
authors.initials: GM
authors.lastname: Dusheiko
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D016174:Hepacivirus / Q000187:drug effects; D006526:Hepatitis C / Q000188:drug therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D012254:Ribavirin / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin
references.citation: Gastroenterol Hepatol (N Y). 2012 Jun;8(6 Suppl 3):1-20
references.pmid: 24944547
references.citation: Gastroenterology. 2011 Jun;140(7):1970-9, 1979.e1-3
references.pmid: 21376047
references.citation: Eur J Gastroenterol Hepatol. 2011 Sep;23(9):747-53
references.pmid: 21691208
references.citation: J Hepatol. 2012 Aug;57(2):260-6
references.pmid: 22521356
references.citation: Med J Aust. 2012 Jun 4;196(10):638-41
references.pmid: 22676879
references.citation: Hepatology. 2012 May;55(5):1620-8
references.pmid: 22331658
references.citation: J Int Assoc Provid AIDS Care. 2013 Sep-Oct;12(5):354-62
references.pmid: 23873217
references.citation: Scand J Gastroenterol. 2011 Jul;46(7-8):962-72
references.pmid: 21623677
references.citation: Liver Int. 2012 Feb;32 Suppl 1:39-43
references.pmid: 22212570
references.citation: Gastroenterology. 2011 Sep;141(3):1067-79
references.pmid: 21699793
references.citation: J Hepatol. 2012 Dec;57(6):1379-90
references.pmid: 22878466
references.citation: Lancet Infect Dis. 2012 Sep;12(9):671-7
references.pmid: 22714001
references.citation: Cochrane Database Syst Rev. 2013 Jan 31;(1):CD003617
references.pmid: 23440791
references.citation: Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):455-62
references.pmid: 23199504
references.citation: J Med Virol. 2013 Jun;85(6):1019-27
references.pmid: 23588727
references.citation: J Hepatol. 2012 Sep;57(3):541-8
references.pmid: 22612998
references.citation: Hepatology. 2013 Apr;57(4):1325-32
references.pmid: 23315914
references.citation: J Hepatol. 2006 Mar;44(3):462-74
references.pmid: 16427156
references.citation: Hepatology. 2012 Nov;56(5):1591-2
references.pmid: 22807004
references.citation: Hepatology. 2011 Jul;54(1):20-7
references.pmid: 21618566
references.citation: J Hepatol. 2013 Jul;59(1):31-7
references.pmid: 23454058
references.citation: Hepatology. 2012 Sep;56(3):850-60
references.pmid: 22454336
references.citation: J Hepatol. 2013 Mar;58(3):445-51
references.pmid: 23142061
references.citation: Lancet. 2013 Jun 15;381(9883):2100-7
references.pmid: 23499440
references.citation: Liver Int. 2013 Feb;33 Suppl 1:56-62
references.pmid: 23286847
references.citation: Aliment Pharmacol Ther. 2009 Jul 1;30(2):146-53
references.pmid: 19392868
references.citation: Lancet Infect Dis. 2013 Jul;13(7):563-4
references.pmid: 23768748
references.citation: Nature. 2009 Sep 17;461(7262):399-401
references.pmid: 19684573
references.citation: Lancet. 1997 Mar 22;349(9055):825-32
references.pmid: 9121257
references.citation: N Engl J Med. 2011 Jun 23;364(25):2405-16
references.pmid: 21696307
references.citation: J Hepatol. 2013 Apr;58(4):792-800
references.pmid: 23137766
references.citation: N Engl J Med. 2007 Nov 29;357(22):2227-36
references.pmid: 18046027
references.citation: J Hepatol. 2013 Sep;59(3):434-41
references.pmid: 23669289
references.citation: Hepatology. 1996 Aug;24(2):289-93
references.pmid: 8690394
references.citation: Am J Gastroenterol. 2011 Jul;106(7):1255-63
references.pmid: 21468012
references.citation: J Viral Hepat. 2012 Feb;19(2):120-7
references.pmid: 22239501
references.citation: Am J Gastroenterol. 2002 Oct;97(10):2614-8
references.pmid: 12385448
references.citation: Can J Infect Dis Med Microbiol. 2012 Spring;23(1):31-5
references.pmid: 23450124
references.citation: Hepatology. 2010 Feb;51(2):388-97
references.pmid: 19918980
references.citation: J Viral Hepat. 2011 Jan;18(1):23-31
references.pmid: 20196799
references.citation: J Hepatol. 1995 Jun;22(6):696-9
references.pmid: 7560864
references.citation: Lancet Infect Dis. 2013 Jul;13(7):597-605
references.pmid: 23768747
references.citation: J Viral Hepat. 2011 Mar;18(3):153-60
references.pmid: 21070503
references.citation: N Engl J Med. 2002 Jul 11;347(2):89-94
references.pmid: 12110736
references.citation: N Engl J Med. 2013 May 16;368(20):1878-87
references.pmid: 23607594
references.citation: Am J Gastroenterol. 2007 Nov;102(11):2589-600
references.pmid: 17850410
references.citation: Hepatology. 2011 Jan;53(1):317-24
references.pmid: 21254179
references.citation: Lancet Infect Dis. 2013 Jun;13(6):497-506
references.pmid: 23523674
references.citation: Ann Intern Med. 2013 Feb 19;158(4):235-45
references.pmid: 23420232
references.citation: Ann Hepatol. 2012 Nov-Dec;11(6):855-61
references.pmid: 23109448
references.citation: Hepatology. 2007 Mar;45(3):579-87
references.pmid: 17326216
references.citation: J Hepatol. 2012 Mar;56(3):696-703
references.pmid: 21767510
references.citation: J Infect Dis. 2013 Mar;207 Suppl 1:S26-32
references.pmid: 23390302
references.citation: N Engl J Med. 2012 Jan 19;366(3):216-24
references.pmid: 22256805
references.citation: Hepatology. 2012 Jan;55(1):49-57
references.pmid: 21898506
references.citation: N Engl J Med. 1988 Jun 30;318(26):1728-33
references.pmid: 3374545
references.citation: N Engl J Med. 2011 Jun 23;364(25):2417-28
references.pmid: 21696308
references.citation: Hepatology. 2002 Jul;36(1):202-10
references.pmid: 12085366
references.citation: Hepatology. 2012 Nov;56(5):1622-30
references.pmid: 22576324
references.citation: Hepatology. 2014 Jan;59(1):46-8
references.pmid: 23813604
references.citation: Clin Infect Dis. 2013 May;56(9):1294-300
references.pmid: 23271787
references.citation: Hepatology. 2009 Apr;49(4):1335-74
references.pmid: 19330875
references.citation: Hepatology. 2009 Dec;50(6):1709-18
references.pmid: 19787809
references.citation: N Engl J Med. 2011 Mar 31;364(13):1195-206
references.pmid: 21449783
references.citation: Gastroenterology. 2012 May;142(6):1293-1302.e4
references.pmid: 22537436
references.citation: Lancet. 2001 Sep 22;358(9286):958-65
references.pmid: 11583749
references.citation: Liver Int. 2013 Feb;33 Suppl 1:46-55
references.pmid: 23286846
references.citation: Clin Dev Immunol. 2012;2012:502156
references.pmid: 22844322
references.citation: Curr HIV/AIDS Rep. 2013 Sep;10(3):226-34
references.pmid: 23832718
references.citation: Hepatology. 2012 Mar;55(3):742-8
references.pmid: 21987462
references.citation: J Hepatol. 2012 Jun;56(6):1247-53
references.pmid: 22326470
references.citation: Liver Int. 2010 Mar;30(3):342-55
references.pmid: 20015149
references.citation: Gastroenterol Hepatol (N Y). 2011 Jul;7(7):445-54
references.pmid: 22298979
references.citation: J Hepatol. 1994 Aug;21(2):241-3
references.pmid: 7989716
references.citation: N Engl J Med. 2013 Jan 3;368(1):45-53
references.pmid: 23281975
references.citation: J Hepatol. 1996 Jan;24(1):38-47
references.pmid: 8834023
references.citation: Gut. 2010 Sep;59(9):1245-51
references.pmid: 20675693
references.citation: Gastroenterology. 2010 Nov;139(5):1577-85, 1585.e1-3
references.pmid: 20708617
references.citation: Clin Gastroenterol Hepatol. 2009 Jun;7(6):696-701
references.pmid: 19514117
references.citation: N Engl J Med. 2009 Aug 6;361(6):580-93
references.pmid: 19625712
references.citation: Liver Int. 2013 Feb;33 Suppl 1:93-104
references.pmid: 23286852
references.citation: Gut. 2008 Apr;57(4):531-6
references.pmid: 18079286
references.citation: Aliment Pharmacol Ther. 2012 Aug;36(4):353-62
references.pmid: 22742526
references.citation: N Engl J Med. 2013 Jan 3;368(1):34-44
references.pmid: 23281974
references.citation: J Viral Hepat. 2012 Jan;19 Suppl 1:18-32
references.pmid: 22233410
references.citation: Ann Intern Med. 2001 Jan 16;134(2):120-4
references.pmid: 11177315
references.citation: Genome Biol. 2008 Jan 23;9(1):R16
references.pmid: 18215275
references.citation: Hepatol Int. 2011 Jun;5(2):625-34
references.pmid: 21484142
references.citation: J Hepatol. 2012 Feb;56(2):455-63
references.pmid: 21884670
references.citation: Transplantation. 2009 Nov 27;88(10):1214-21
references.pmid: 19935376
references.citation: J Hepatol. 2008 Aug;49(2):274-87
references.pmid: 18571272
references.citation: Expert Opin Pharmacother. 2010 Mar;11(4):571-7
references.pmid: 20163268
references.citation: Gut. 2010 Jan;59(1):1-5
references.pmid: 20007952
references.citation: Hepatology. 1999 Oct;30(4):1054-8
references.pmid: 10498659
references.citation: Gastroenterology. 2010 Apr;138(4):1338-45, 1345.e1-7
references.pmid: 20060832
references.citation: J Viral Hepat. 2012 Feb;19(2):112-9
references.pmid: 22239500
references.citation: N Engl J Med. 2013 Aug 15;369(7):630-9
references.pmid: 23944300
references.citation: HIV Clin Trials. 2012 May-Jun;13(3):142-52
references.pmid: 22592094
references.citation: Lancet. 2010 Aug 28;376(9742):705-16
references.pmid: 20692693
references.citation: N Engl J Med. 2002 Sep 26;347(13):975-82
references.pmid: 12324553
references.citation: Liver Transpl. 2012 Sep;18(9):1053-9
references.pmid: 22706796
references.citation: Semin Liver Dis. 2000;20(1):17-35
references.pmid: 10895429
references.citation: N Engl J Med. 2011 Mar 31;364(13):1207-17
references.pmid: 21449784
references.citation: N Engl J Med. 2013 May 16;368(20):1867-77
references.pmid: 23607593
references.citation: World J Gastroenterol. 1999 Aug;5(4):301-304
references.pmid: 11819452
references.citation: J Hepatol. 2011 Aug;55(2):245-64
references.pmid: 21371579
references.citation: Lancet Infect Dis. 2013 May;13(5):401-8
references.pmid: 23499158
references.citation: Int J Psychiatry Med. 2010;40(2):199-215
references.pmid: 20848876
references.citation: Lancet. 2010 Oct 30;376(9751):1467-75
references.pmid: 20951424
references.citation: Hepatology. 2007 Sep;46(3):631-9
references.pmid: 17680654
references.citation: Hepatology. 2008 Aug;48(2):418-31
references.pmid: 18563841
references.citation: Eur J Radiol. 2012 Dec;81(12):4112-8
references.pmid: 23000186
references.citation: Magn Reson Med Sci. 2012;11(4):291-7
references.pmid: 23269016
references.citation: N Engl J Med. 2011 Sep 15;365(11):1014-24
references.pmid: 21916639
references.citation: J Viral Hepat. 2008 Feb;15(2):115-9
references.pmid: 18184194